IA
CALT

IFP Advisors’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

IFP Advisors’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-350
Closed -$7K – 4534
2022
Q4 		$7K Hold
350
– – ﹤0.01% 3650
2022
Q3 		$7K Buy
+350
New +$6.1K ﹤0.01% 3895

Other funds holding CALT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors's CALT Position: Q1 2023 in Review

IFP Advisors sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q1 2023, closing a stake of 350 shares — an estimated $7K sold.

IFP Advisors first reported a position in CALT in Q3 2022 and held it in 2 quarters. The position peaked at $7K in Q4 2022. 14 funds tracked by Wall St. Rank hold CALT as of Q1 2023.

  • IFP Advisors reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 350 Calliditas Therapeutics AB American Depositary Shares shares in Q1 2023, an estimated $7K.
  • IFP Advisors first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q3 2022 and held it in 2 quarters.
  • IFP Advisors's Calliditas Therapeutics AB American Depositary Shares position peaked at $7K in Q4 2022.
  • 14 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.